Literature DB >> 9675310

Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine.

M S Webb1, D Saxon, F M Wong, H J Lim, Z Wang, M B Bally, L S Choi, P R Cullis, L D Mayer.   

Abstract

Poly(ethylene glycol) (PEG) conjugated lipids have been used to increase the circulation longevity of liposomal carriers encapsulating therapeutic compounds. PEG is typically conjugated to distearoylphosphatidylethanolamine (DSPE) via a carbamate linkage that results in a net negative charge on the phosphate moiety at physiological pH. It was anticipated that the presence of this negative charge could have deleterious effects on liposome pharmacokinetic characteristics. We describe here the synthesis of a new class of neutrally charged PEG-lipid conjugates in which the PEG moiety was linked to ceramide (CER). These PEG-CER conjugates were compared with PEG-DSPE conjugates for their effects on the pharmacokinetics of liposomal vincristine. PEG-CER (78% palmitic acid, C16) and PEG-DSPE achieved comparable increases in the circulation lifetimes of sphingomyelin/cholesterol (SM/chol) liposomes. However, PEG-DSPE significantly increased the in vitro and in vivo leakage rates of vincristine from SM/chol-based liposomes compared to vincristine leakage observed when PEG-CER was used. The increase in drug leakage observed in vitro that was due to the presence of PEG-DSPE was likely due to the presence of a negative surface charge. Analysis of the electrophoretic mobilities of these formulations suggested that the negative surface charges were shielded by approx. 80% by the PEG layer extending from the membrane surface. In contrast, formulations containing PEG-CER had no surface charge and no electrophoretic mobility. A comparison of the effects of the ceramide acyl chain length (C8 through C24) on the pharmacokinetics of SM/chol/PEG-CER formulations of vincristine demonstrated that longer acyl chains on the PEG-CER were associated with longer circulation lifetimes of the liposomal carriers and, consequently, higher plasma vincristine concentrations. These data suggest that the short chain PEG-ceramides underwent rapid partitioning from the vesicles after i.v. administration, whereas the longer chain PEG-ceramides had stronger anchoring properties in the liposome bilayers and partitioned slowly from the administered vesicles. These data demonstrate the utility of ceramide-based steric stabilizing lipids as well as the potential for developing controlled release formulations by manipulating the retention of the PEG-ceramide conjugate in liposome bilayers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9675310     DOI: 10.1016/s0005-2736(98)00077-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  31 in total

1.  Development of Liposomal Gemcitabine with High Drug Loading Capacity.

Authors:  Hassan Tamam; Jinho Park; Hytham H Gadalla; Andrea R Masters; Jelan A Abdel-Aleem; Sayed I Abdelrahman; Aly A Abdelrahman; L Tiffany Lyle; Yoon Yeo
Journal:  Mol Pharm       Date:  2019-06-14       Impact factor: 4.939

2.  Exploring the HYDRAtion method for loading siRNA on liposomes: the interplay between stability and biological activity in human undiluted ascites fluid.

Authors:  George R Dakwar; Kevin Braeckmans; Wim Ceelen; Stefaan C De Smedt; Katrien Remaut
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

3.  Multiple lipid compartments slow vesicle contents release in lipases and serum.

Authors:  Cecile Boyer; Joseph A Zasadzinski
Journal:  ACS Nano       Date:  2007-10       Impact factor: 15.881

4.  The effect of cholesterol domains on PEGylated liposomal gene delivery in vitro.

Authors:  Long Xu; Michael F Wempe; Thomas J Anchordoquy
Journal:  Ther Deliv       Date:  2011-04

5.  Antibacterial efficacy of gentamicin encapsulated in pH-sensitive liposomes against an in vivo Salmonella enterica serovar typhimurium intracellular infection model.

Authors:  C Cordeiro; D J Wiseman; P Lutwyche; M Uh; J C Evans; B B Finlay; M S Webb
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

6.  Glucose modulation induces reactive oxygen species and increases P-glycoprotein-mediated multidrug resistance to chemotherapeutics.

Authors:  N A Seebacher; D R Richardson; P J Jansson
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

Review 7.  Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.

Authors:  Long Xu; Thomas Anchordoquy
Journal:  J Pharm Sci       Date:  2011-01       Impact factor: 3.534

8.  Interactions of adriamycin, cytochrome c, and serum albumin with lipid monolayers containing poly(ethylene glycol)-ceramide.

Authors:  Hongxia Zhao; Patricia M Dubielecka; Tim Söderlund; Paavo K J Kinnunen
Journal:  Biophys J       Date:  2002-08       Impact factor: 4.033

9.  An optical and microPET assessment of thermally-sensitive liposome biodistribution in the Met-1 tumor model: Importance of formulation.

Authors:  E E Paoli; D E Kruse; J W Seo; H Zhang; A Kheirolomoom; K D Watson; P Chiu; H Stahlberg; K W Ferrara
Journal:  J Control Release       Date:  2009-12-16       Impact factor: 9.776

Review 10.  Self-assembled lipid nanomedicines for siRNA tumor targeting.

Authors:  Yu-Cheng Tseng; Leaf Huang
Journal:  J Biomed Nanotechnol       Date:  2009-08       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.